TY  - GEN
AU  - Schmidt,Nina
AU  - Dressel,Alexander
AU  - Grammer,Tanja B
AU  - Gouni-Berthold,Ioanna
AU  - Julius,Ulrich
AU  - Kassner,Ursula
AU  - Klose,Gerald
AU  - König,Christel
AU  - Koenig,Wolfgang
AU  - Otte,Britta
AU  - Parhofer,Klaus G
AU  - Reinhard,Wibke
AU  - Schatz,Ulrike
AU  - Schunkert,Heribert
AU  - Steinhagen-Thiessen,Elisabeth
AU  - Vogt,Anja
AU  - Laufs,Ulrich
AU  - März,Winfried
TI  - Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry
SN  - 1879-1484
PY  - 2019///1101
KW  - Adult
KW  - Anticholesteremic Agents
KW  - therapeutic use
KW  - Biomarkers
KW  - blood
KW  - Cardiovascular Diseases
KW  - epidemiology
KW  - Cholesterol, LDL
KW  - Down-Regulation
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Germany
KW  - Heredity
KW  - Humans
KW  - Hyperlipoproteinemia Type II
KW  - Male
KW  - Middle Aged
KW  - PCSK9 Inhibitors
KW  - Pedigree
KW  - Phenotype
KW  - Proprotein Convertase 9
KW  - metabolism
KW  - Risk Assessment
KW  - Risk Factors
KW  - Serine Endopeptidases
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.atherosclerosis.2018.08.050
ER  -